GBI Research’s report, “Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 – Europe (Germany, France, Italy, UK and Spain)” provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data by revenue and volume over the 2006-2020 period for the following countries: Germany, France, UK, Italy and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Information on market size for the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations- Annualized sales data by revenue for the 2006-2020 period and company share data by revenue for 2013- Annualized sales data by volume for the 2006-2020 period- Coverage of key geographies: Germany, France, UK, Italy and Spain.
Read more sample reports of medical devices at:
Reasons to buy
• Derive actionable insights from value-volume relationships
• Analyze value-volume relationships and provide direction to marketing and sales strategies
• Develop market-entry and market-expansion strategies
• Identify the key players best positioned to take advantage of opportunities in the European market
Read this report at LinkedIn
Latest Report by Radiant Insights:
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 – Increasing Uptake of Novel Drug Classes to Drive Market Growth:
Frontier Pharma: Prostate Cancer – Identifying and Commercializing First-in-Class Innovation:
The prostate cancer pipeline is among the largest in the pharmaceutical industry with 484 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in this pipeline is exceptional; GBI Research analysis identified 174 first-in-class programs in the prostate cancer pipeline, acting on 122 first-in-class molecular targets.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States